NASDAQ : INCR

InterCure Ltd. — Financial statements

Healthcare · Drug Manufacturers - Specialty & Generic · Israel

Last price 3.97 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 51.59M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

InterCure Ltd. (INCR) reported revenue of 270.20M ILS (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in ILS.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue270.20M270.20M238.84M355.55M388.68M219.68M
Cost of Revenue229.50M229.50M196.79M246.95M216.67M117.11M
Gross Profit40.70M40.70M42.05M108.60M172.01M102.56M
Selling, General & Admin93.40M93.40M107.89M95.88M92.61M50.42M
Research & Development390.00K390.00K414.00K388.00K632.00K1.24M
Other Operating Expenses11.73M11.73M19.35M9.64M29.63M14.40M
Operating Expenses107.94M107.94M129.94M108.50M131.78M72.51M
Operating Income-67.24M-67.24M-87.89M105.00K40.23M30.05M
Interest Expense-19.66M-19.66M-20.64M-24.22M-14.69M-418.00K
Interest & Investment Income1.55M1.55M2.70M5.38M844.00K130.00K
Earnings From Equity Investments296.00K296.00K
Currency Exchange Gain (Loss)1.42M1.42M-23.00K-46.00K7.33M-4.54M
Other Non Operating Income (Expenses)-171.00K-171.00K-2.15M-828.00K-266.00K-4.63M
EBT Excluding Unusual Items-83.80M-83.80M-108.00M-19.61M33.44M20.60M
Impairment of Goodwill-63.10M
Gain (Loss) on Sale of Investments-30.07M-30.07M-12.22M-3.00M-174.00K-1.87M
Asset Writedown-4.59M
Other Unusual Items69.77M69.77M32.90M29.01M10.57M
Pretax Income-44.10M-44.10M-87.32M-61.28M43.84M18.73M
Income Tax Expense-7.32M-7.32M-14.53M2.25M93.00K11.44M
Earnings From Continuing Operations-36.78M-36.78M-72.79M-63.53M43.75M7.29M
Minority Interest in Earnings1.07M1.07M5.00M1.57M1.07M-2.60M
Net Income-35.71M-35.71M-67.80M-61.96M44.82M4.69M
Net Income to Common-35.71M-35.71M-67.80M-61.96M44.82M4.69M
Shares Outstanding (Basic)10.75M10.75M9.17M9.11M9.07M7.70M
Shares Outstanding (Diluted)10.75M10.75M9.17M9.11M9.07M8.17M
EPS (Basic)-3.32-3.32-7.39-6.804.940.61
EPS (Diluted)-3.32-3.32-7.40-6.804.940.55
Free Cash Flow13.29M13.29M-71.30M-56.25M31.52M16.11M
Free Cash Flow Per Share1.241.24-7.77-6.173.481.97
Gross Margin15.06%15.06%17.61%30.54%44.26%46.69%
Operating Margin-24.89%-24.89%-36.80%0.03%10.35%13.68%
Profit Margin-13.22%-13.22%-28.38%-17.43%11.53%2.14%
Free Cash Flow Margin4.92%4.92%-29.85%-15.82%8.11%7.33%
EBITDA-55.34M-55.34M-78.22M13.27M51.93M37.45M
EBITDA Margin-20.48%-20.48%-32.75%3.73%13.36%17.05%
D&A For EBITDA11.90M11.90M9.67M13.17M11.70M7.39M
EBIT-67.24M-67.24M-87.89M105.00K40.23M30.05M
EBIT Margin-24.89%-24.89%-36.80%0.03%10.35%13.68%
Effective Tax Rate0.21%61.07%

Balance sheet

Fiscal year January - December; amounts in ILS.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents46.47M46.47M78.32M101.14M232.59M196.22M
Trading Asset Securities209.00K209.00K333.00K187.00K205.00K330.00K
Cash & Short-Term Investments46.67M46.67M78.65M101.33M232.79M196.55M
Accounts Receivable21.79M21.79M52.45M61.12M40.76M18.59M
Other Receivables126.52M126.52M87.19M69.12M24.84M14.26M
Receivables154.47M154.47M180.50M170.78M129.95M37.53M
Inventory108.01M108.01M120.31M105.47M140.13M62.31M
Prepaid Expenses1.14M1.14M1.51M1.28M3.13M4.98M
Restricted Cash2.03M2.03M1.32M9.66M13.91M21.08M
Other Current Assets4.42M4.42M9.52M30.29M7.58M13.71M
Total Current Assets316.75M316.75M391.80M418.80M527.49M336.16M
Property, Plant & Equipment102.81M102.81M105.24M97.47M103.13M86.51M
Long-Term Investments1.02M1.02M2.15M1.92M2.56M2.56M
Goodwill219.19M219.19M224.59M221.08M284.18M268.29M
Long-Term Deferred Tax Assets45.99M45.99M38.37M24.68M20.64M3.02M
Other Long-Term Assets4.79M4.79M423.00K4.21M20.00M
Total Assets690.55M690.55M762.57M786.61M958.01M696.54M
Accounts Payable68.14M68.14M77.54M78.44M126.07M64.47M
Accrued Expenses17.27M17.27M14.35M12.50M10.59M11.20M
Short-Term Debt11.00M11.00M1.09M1.72M
Current Portion of Long-Term Debt88.80M88.80M69.44M88.19M126.94M70.56M
Current Portion of Leases4.26M4.26M4.79M4.64M4.35M3.31M
Current Unearned Revenue8.06M2.90M
Other Current Liabilities24.89M24.89M60.64M42.09M35.63M39.42M
Total Current Liabilities214.37M214.37M226.75M225.87M312.72M193.59M
Long-Term Debt59.46M59.46M113.98M82.20M99.68M11.95M
Long-Term Leases19.49M19.49M23.20M20.64M23.10M21.37M
Pension & Post-Retirement Benefits881.00K881.00K973.00K841.00K1.02M224.00K
Total Liabilities294.19M294.19M364.90M329.55M436.53M227.13M
Common Stock675.60M675.60M658.60M643.16M632.02M623.57M
Retained Earnings-314.62M-314.62M-277.58M-204.00M-141.65M-186.47M
Comprehensive Income & Other35.54M35.54M15.95M15.95M10.93M10.93M
Total Common Equity396.52M396.52M396.97M455.11M501.31M448.03M
Minority Interest-164.00K-164.00K702.00K1.95M20.17M21.38M
Shareholders' Equity396.36M396.36M397.67M457.06M521.48M469.41M
Total Liabilities & Equity690.55M690.55M762.57M786.61M958.01M696.54M
Total Debt183.01M183.01M211.40M195.68M255.16M108.91M
Net Cash (Debt)-136.34M-136.34M-132.75M-94.35M-22.37M87.64M
Net Cash Per Share-12.68-12.68-14.47-10.35-2.4710.73
Filing Date Shares Outstanding10.94M10.94M9.43M9.11M9.11M9.03M
Total Common Shares Outstanding10.94M10.94M9.43M9.11M9.11M9.03M
Working Capital102.38M102.38M165.05M192.94M214.77M142.57M
Book Value Per Share36.2636.2642.0949.9355.0049.63
Tangible Book Value177.33M177.33M172.38M234.03M217.12M179.74M
Tangible Book Value Per Share16.2116.2118.2725.6823.8219.91
Buildings102.07M102.07M91.29M78.20M70.13M58.80M
Machinery28.00M28.00M24.83M23.41M22.42M12.08M

Cash flow statement

Fiscal year January - December; amounts in ILS.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-35.71M-35.71M-67.80M-61.96M44.82M4.69M
Depreciation & Amortization17.15M17.15M15.37M13.17M11.70M7.39M
Loss (Gain) From Sale of Assets3.27M3.27M-932.00K412.00K
Asset Writedown & Restructuring Costs67.69M
Loss (Gain) From Sale of Investments2.15M2.15M-371.00K661.00K172.00K1.87M
Stock-Based Compensation2.43M2.43M2.28M2.59M8.91M6.45M
Other Operating Activities8.68M8.68M-6.29M12.65M-11.31M11.38M
Change in Accounts Receivable30.84M30.84M8.43M-23.49M-18.29M8.39M
Change in Inventory10.98M10.98M-13.24M34.66M-75.19M-15.47M
Change in Accounts Payable-8.82M-8.82M-8.90M-47.63M57.03M2.79M
Change in Other Net Operating Assets-14.13M-14.13M4.52M-54.72M33.42M2.64M
Operating Cash Flow16.84M16.84M-66.93M-53.63M51.27M30.14M
Capital Expenditures-3.55M-3.55M-4.38M-2.62M-19.74M-14.03M
Sale of Property, Plant & Equipment25.00K
Cash Acquisitions-114.00K-114.00K1.11M-4.20M-14.48M-22.59M
Divestitures2.43M2.43M-253.00K
Sale (Purchase) of Intangibles-450.00K
Investment in Securities-651.00K-651.00K-1.25M
Other Investing Activities242.00K242.00K8.59M5.43M6.96M-20.00M
Investing Cash Flow-1.99M-1.99M17.69M4.77M-142.50M-65.21M
Long-Term Debt Issued21.15M21.15M188.44M62.73M263.47M75.46M
Total Debt Issued21.15M21.15M188.44M62.73M263.47M75.46M
Long-Term Debt Repaid-50.28M-50.28M-180.70M-124.71M-125.74M-9.63M
Lease Payments-5.01M-5.01M-5.46M-4.71M-3.88M-2.57M
Net Debt Issued (Repaid)-29.13M-29.13M7.74M-61.98M137.73M65.83M
Issuance of Common Stock1.50M1.50M34.00M137.23M
Other Financing Activities-19.03M-19.03M-15.29M-20.91M-17.28M-5.12M
Financing Cash Flow-46.66M-46.66M26.45M-82.89M120.45M197.94M
Foreign Exchange Rate Adjustments-44.00K-44.00K-39.00K297.00K7.16M-4.54M
Net Cash Flow-31.85M-31.85M-22.82M-131.45M36.37M158.33M
Free Cash Flow13.29M13.29M-71.30M-56.25M31.52M16.11M
Free Cash Flow Margin4.92%4.92%-29.85%-15.82%8.11%7.33%
Free Cash Flow Per Share1.241.24-7.77-6.173.481.97
Levered Free Cash Flow-37.43M-37.43M-31.19M-72.02M-75.91M7.05M
Unlevered Free Cash Flow-25.14M-25.14M-18.28M-56.89M-66.73M7.31M
Free Cash Flow After Leases8.29M8.29M-76.76M-60.96M27.64M13.53M
Cash Interest Paid19.03M19.03M15.19M20.91M17.28M5.12M
Cash Income Tax Paid-306.00K-306.00K12.89M7.61M7.97M11.80M
Change in Working Capital18.88M18.88M-9.19M-91.17M-3.02M-1.65M

Ratios

Fiscal year January - December; amounts in ILS.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization50.37M55.50M74.61M58.60M156.56M299.74M
Enterprise Value93.72M95.92M110.90M80.51M159.19M264.42M
Last Close Price3.974.557.956.4516.5032.40
PE Ratio12.28198.78
PS Ratio0.580.661.140.591.424.24
PB Ratio0.400.450.680.461.061.99
P/TBV Ratio0.891.001.580.902.545.19
P/FCF Ratio11.6613.3117.4657.88
P/OCF Ratio9.2110.5110.7430.94
EV/Sales Ratio1.091.131.690.811.443.74
EV/EBITDA Ratio21.8510.7821.96
EV/EBIT Ratio2,761.2813.9127.37
EV/FCF Ratio21.9123.0117.7651.06
Debt / Equity Ratio0.460.460.530.430.490.23
Debt / EBITDA Ratio14.744.912.91
Debt / FCF Ratio13.7713.778.096.76
Net Debt / Equity Ratio0.340.340.330.210.04-0.19
Net Debt / EBITDA Ratio-2.46-2.46-1.707.110.43-2.34
Net Debt / FCF Ratio10.2610.26-1.86-1.680.71-5.44
Asset Turnover0.370.370.310.410.470.43
Inventory Turnover2.012.011.742.012.142.88
Quick Ratio0.910.910.961.020.951.19
Current Ratio1.481.481.731.851.691.74
Return on Equity (ROE)-9.26%-9.26%-17.03%-12.98%8.83%1.92%
Return on Assets (ROA)-5.78%-5.78%-7.09%0.01%3.04%3.67%
Return on Invested Capital (ROIC)-12.62%-12.65%-16.25%0.02%8.67%3.65%
Return on Capital Employed (ROCE)-14.10%-14.10%-16.40%0.00%6.20%6.00%
Earnings Yield-26.12%-20.18%-24.95%-29.36%8.14%0.50%
FCF Yield8.57%7.51%-26.24%-26.65%5.73%1.73%
Buyback Yield / Dilution-17.17%-17.17%-0.65%-0.48%-11.05%-60.81%